Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.’s Net Profit Rose 19.2% in First Three Quarters of 2021

Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (浙江我武生物科技股份有限公司) (300357.SZ) reported a net profit of 266.3 million yuan in the first three quarters of 2021, up 19.2% year-on-year.

Meanwhile, the company posted 619.7 million yuan in revenue, up 26.2% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 123.7 million yuan in total liabilities, with a liability-to-asset ratio of 6.7%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.